
Allovir Inc (KLRS) Earnings Dates & Reports
Allovir Inc (KLRS) Most Recent Earnings
Report DateAug 13, 2025
Period EndingQ2 2025
Est. EPS-$0.51
Actual EPS-$0.61
EarningsMiss
Allovir Inc (KLRS) Earnings
View the latest Allovir Inc (KLRS) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Allovir Inc (KLRS)
Order type
Buy in
Order amount
Est. shares
0 shares
Allovir Inc (KLRS) Earnings per Share (EPS) History
Signup for full accessBrowse free
Allovir Inc (KLRS) Latest Earnings
The value each KLRS share was expected to gain vs. the value each share gained.
Allovir Inc (KLRS) reported its most recent earnings on Aug 13, 2025 for Q2 2025, posting earnings per share (EPS) of -$0.61. This exceeded analysts' expectations of -$0.51 by 19.61%, marking a Miss.
For comparison, Allovir Inc reported EPS of $0 in the same quarter last year.
The company is expected to announce its next earnings report on 11/15/2025, with analysts projecting an EPS of -$0.63.
Allovir Inc (KLRS) Earnings History
Allovir Inc (KLRS) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Allovir Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
Report date | Price 1D before | Price 1D after | Change |
---|---|---|---|
Aug 13, 2025 | — | — | — |
Allovir Inc (KLRS) Earnings FAQs
Allovir Inc (KLRS) last reported earnings on Aug 13, 2025 for Q2 2025, posting an EPS of -$0.61, which Miss the estimate of -$0.51 by 19.61%.
For Q2 2025, Allovir Inc (KLRS) reported an EPS of -$0.61, missing analysts' estimate of -$0.51 by 19.61%.
For Q2 2025, Allovir Inc (KLRS) Miss expectations with an actual EPS of -$0.61 vs. an estimated EPS of -$0.51.
Following the last earnings report on Aug 13, 2025, Allovir Inc (KLRS)'s stock price moved — from — to —.
The next Allovir Inc (KLRS) earnings call is scheduled for Nov. 15, 2025, where executives will discuss financial results and outlook.